Pavel Boštík

1.5k total citations
76 papers, 1.2k citations indexed

About

Pavel Boštík is a scholar working on Epidemiology, Virology and Immunology. According to data from OpenAlex, Pavel Boštík has authored 76 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 27 papers in Virology and 27 papers in Immunology. Recurrent topics in Pavel Boštík's work include HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (19 papers) and T-cell and B-cell Immunology (14 papers). Pavel Boštík is often cited by papers focused on HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (19 papers) and T-cell and B-cell Immunology (14 papers). Pavel Boštík collaborates with scholars based in Czechia, United States and Norway. Pavel Boštík's co-authors include Aftab A. Ansari, François Villinger, Ann E. Mayne, Kazuyasu Mori, J. Bruce Sundstrom, Jana Olšovská, Martin Dušek, Alexandr Mikyška, Pavel Čermák and Kateřina Bogdanová and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Pavel Boštík

72 papers receiving 1.2k citations

Peers

Countries citing papers authored by Pavel Boštík

Since Specialization

Citations

This map shows the geographic impact of Pavel Boštík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Boštík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Boštík more than expected).

Fields of papers citing papers by Pavel Boštík

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel Boštík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Boštík. The network helps show where Pavel Boštík may publish in the future.

Co-authorship network of co-authors of Pavel Boštík

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Boštík. A scholar is included among the top collaborators of Pavel Boštík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Boštík. Pavel Boštík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Czech Honeydew Honeys—A Potential Source of Local Medical Honey with Strong Antimicrobial Activity 2024 ·Pharmaceuticals ·(unknown), (unknown), (unknown), (unknown), Pavel Boštík	3
2	Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe 2024 ·Annals of Clinical Microbiology and Antimicrobials ·(unknown), (unknown), (unknown), (unknown), I. Pavlík, Pavel Boštík	0
3	Comparison of adverse reactions of spiramycin versus pyrimethamine/sulfadiazine treatment of toxoplasmosis in pregnancy: is spiramycin really the drug of choice for unproven infection of the fetus? 2023 ·The Journal of Maternal-Fetal & Neonatal Medicine ·(unknown), (unknown), Marián Kacerovský, Pavel Boštík	5
4	A Rare Case of Osteomyelitis of an Ankle Caused by Mycobacterium chelonae 2023 ·Antibiotics ·(unknown), (unknown), Radka Bolehovská, (unknown), (unknown), Tomáš Kučera, I. Pavlík, Pavel Boštík, Pavel Ryška	1
5	Heterogeneity of post-COVID impairment: interim analysis of a prospective study from Czechia 2021 ·Virology Journal ·(unknown), Michal Svoboda, (unknown), (unknown), (unknown), (unknown), Viktor Chrobok, Pavel Boštík, (unknown), (unknown), (unknown), (unknown), Vladimír Koblížek	15
6	A rare case of purulent meningitis caused by Capnocytophaga canimorsus in the Czech Republic – case report and review of the literature 2020 ·BMC Infectious Diseases ·(unknown), (unknown), (unknown), Pavel Boštík	8
7	Magnetoconductive maghemite core/polyaniline shell nanoparticles: Physico-chemical and biological assessment 2016 ·Colloids and Surfaces B Biointerfaces ·(unknown), Patrycja Bober, (unknown), Eduard Petrovský, Pavel Boštík, (unknown)	15
8	Vybrané virové a bakteriální perinatálně přenosné infekce - pohlavní infekce 2015 ·Pediatrie pro praxi ·(unknown), (unknown), (unknown), Pavel Boštík	0
9	[Infections caused by human alpha herpes viruses]. 2014 ·PubMed ·(unknown), (unknown), Jan Smetana, (unknown), (unknown), Miroslav Špliňo, Pavel Boštík	5
10	[Ocular toxoplasmosis - seeking a strategy for treatment]. 2014 ·PubMed ·(unknown), (unknown), Pavel Boštík	3
11	Molecular epidemiology of varicella zoster virus. 2010 ·PubMed ·(unknown), Pavel Boštík, Roman Chlíbek, (unknown), (unknown), Jan Smetana, Miroslav Špliňo	3
12	Decreased NK Cell Frequency and Function Is Associated with Increased Risk of KIR3DL Allele Polymorphism in Simian Immunodeficiency Virus-Infected Rhesus Macaques with High Viral Loads 2009 ·The Journal of Immunology ·Pavel Boštík, (unknown), Weining Tang, François Villinger, Lara Pereira, Dawn Little, Susan T. Stephenson, Mark Bouzyk, Aftab A. Ansari	44
13	Maintenance of CD4+ T cell TCR Vβ repertoire heterogeneity is characteristic of apathogenic SIV infection in non-human primate model of AIDS 2007 ·Virology ·Pavel Boštík, Susan T. Stephenson, Rebecca M. Lynch, (unknown), Aftab A. Ansari	3
14	Optimization of in vitro expansion of macaque CD4⁺ T cells using anti‐CD3 and co‐stimulation for autotransfusion therapy 2006 ·Journal of Medical Primatology ·Nattawat Onlamoon, (unknown), (unknown), Ann E. Mayne, Mark Bonyhadi, (unknown), J. Bruce Sundstrom, Pavel Boštík, Aftab A. Ansari, François Villinger	15
15	Relative Resistance in the Development of T Cell Anergy in CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys 2001 ·The Journal of Immunology ·Pavel Boštík, Ann E. Mayne, François Villinger, Kenneth P. Greenberg, Jonathan D. Powell, Aftab A. Ansari	22
16	Effects of Norepinephrine, HIV Type 1 Infection, and Leukocyte Interactions with Endothelial Cells on the Expression of Matrix Metalloproteinases 2001 ·AIDS Research and Human Retroviruses ·J. Bruce Sundstrom, Mario Mosunjac, (unknown), Pavel Boštík, Robert M. Donahoe, M. B. Gravanis, Aftab A. Ansari	12
17	Failure to Expand Influenza and Tetanus Toxoid Memory T Cells in Vitro Correlates with Disease Course in SIV Infected Rhesus Macaques 2001 ·Cellular Immunology ·Aftab A. Ansari, Pavel Boštík, Ann E. Mayne, François Villinger	11
18	Induction of Long-Term Protective Effects against Heterologous Challenge in SIVhu-Infected Macaques 2000 ·Virology ·(unknown), William M. Switzer, Bharat Parekh, Ronald A. Otten, Debra Adams, Vedapuri Shanmugam, Pavel Boštík, Ann E. Mayne, Nathaniel F. Chikkala, Harold M. McClure, Francis J. Novembre, Qizhi Yao, Walid Heneine, Thomas M. Folks, Aftab A. Ansari	12
19	Inverse Correlation of Telomerase Activity/Proliferation of CD4+ T Lymphocytes and Disease Progression in Simian Immunodeficiency Virus–Infected Nonhuman Primates 2000 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Pavel Boštík, Gary T. Brice, Kenneth P. Greenberg, Ann E. Mayne, (unknown), Mark G. Lewis, Aftab A. Ansari	11
20	In Vitro and in Vivo Responses to Interleukin 12 Are Maintained until the Late SIV Infection Stage but Lost during AIDS 2000 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Nathaniel F. Chikkala, (unknown), Pavel Boštík, (unknown), Jon Adams, M E Lee, Francis J. Novembre, Maurice K. Gately, Aftab A. Ansari, Christopher D. Hillyer	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact